Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
3.590
-0.050 (-1.37%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Immuneering Market Cap
Immuneering has a market cap or net worth of $232.26 million as of October 16, 2026. It is the 19,893rd most valuable company in the world and the 3,437th biggest in the United States. Its market cap has decreased by 40.38% in one year.
Market Cap
232.26M
Enterprise Value
53.22M
1-Year Change
-40.38%
Global Rank
Country Rank
#3,437 United States
Category
ChartMarket Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $232.26M, a decrease of -36.51%. That is a compound annual growth rate of -8.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 232.26M | -45.33% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Century Therapeutics | 248.07M |
| Lineage Cell Therapeutics | 247.42M |
| Palisade Bio | 245.72M |
| Vanda Pharmaceuticals | 243.66M |
| Bicycle Therapeutics | 242.18M |
| Rocket Pharmaceuticals | 239.31M |
| Cabaletta Bio | 239.06M |
| AC Immune | 237.63M |